Tess E. Wallace1, Andrew J. Patterson2, Oshaani Abeyakoon1, Reem Bedair1, Roie Manavaki1, Mary A. McLean3, James P. B. O'Connor4, Martin J. Graves2, and Fiona J. Gilbert1
1Department of Radiology, University of Cambridge, Cambridge, United Kingdom, 2Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom, 3Cancer Research UK Cambridge Institute, Cambridge, United Kingdom, 4Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom
Synopsis
Blood
oxygenation level-dependent (BOLD) MRI with hyperoxic/hypercapnic gas stimuli
has potential to non-invasively probe vascular function, which could help
characterize tumors, predict treatment susceptibility and monitor response.
This work evaluates BOLD contrast changes in healthy breast parenchyma in
response to air and oxygen interleaved with 2% and 5% carbogen gas mixtures,
relative to an all-air control. We found that oxygen vs. 5% carbogen was the
most robust stimulus for inducing BOLD contrast in the breast. Measurements may
be confounded by physiological fluctuations and menstrual cycle changes. Response
in breast carcinoma was variable and may indicate underlying differences in
vascular function.Introduction
Angiogenesis
in solid tumors gives rise to a relatively high fraction of immature blood
vessels, which represents an attractive therapeutic target. Non-invasive methods that probe vascular function would have potential in characterizing individual tumors, predicting treatment susceptibility, and monitoring response. Blood oxygenation level-dependent (BOLD) MRI in conjunction with
hyperoxic/hypercapnic gas stimuli has been proposed as a functional biomarker
of vessel maturity
1–3. Immature
vessels lacking appropriate smooth muscle vasculature should be unable to
dilate or constrict in response to vasoactive challenges, whereas surrounding
healthy mature vessels should respond
3. However, previous optical imaging studies have suggested that these
measurements may be confounded by the body’s low frequency hemodynamic
fluctuations
4. In this study we evaluated BOLD response to carbogen interleaved with
air and oxygen, relative to an air-only control experiment in healthy breast
parenchyma. We also tested the relative efficacy of carbogen (5% CO
2,
95% O
2) and ‘carbogen-light’ (2% CO
2, 98% O
2)
in inducing a BOLD vasomotor response. The optimal stimulus design was
evaluated in a small patient cohort.
Methods
Data Acquisition: MR
imaging was performed at 3T (MR750, GE Healthcare, Waukesha, WI) in 19 healthy premenopausal volunteers (aged 22–39 years) using a multi-phase single-shot fast
spin echo sequence to acquire sequential T2-weighted sagittal breast
images at a single slice location. Imaging parameters were as follows: TR 4s,
TE 58ms, bandwidth ±83kHz, matrix size 128x128, FOV 20cm, slice thickness 5mm.
The modulated gas stimulus design consisted of 2% (n=9) and 5% (n=10) carbogen gas
mixtures interleaved with either medical air or oxygen in two-minute blocks,
for four cycles (Figure 1). A twelve-minute medical air breathing period was
used to determine background physiological noise. Gases were administered to
the subject via an OxyMask™ (Southmedic Inc., Barrie, ON) at a flow rate of
14L/min, with switching controlled by an in-house gas delivery system. The
number of days from participants’ last menstrual period at the time of the MR
examination was noted. Five patients (aged 29–59 years) with histologically proven breast cancer were scanned using the same BOLD MRI protocol,
but only the optimal stimulus design was delivered. Tumor ROIs were delineated by a radiologist on slice-matched post-contrast images. Data Analysis: A non-rigid
registration algorithm5 was employed to mitigate respiratory motion artifacts. The
first cycle of data was discarded to allow equilibration of the gas inhalation
regime. Baseline subtraction of the line of best fit through the data was performed to eliminate linear drift. Signal intensity response for each pixel meeting a certain signal-to-noise threshold was then cross-correlated
with a sine and cosine function at the stimulus frequency (0.0042 Hz), yielding
pixel-wise measures of the correlation and phase lag between the delivered
stimuli and measured BOLD contrast. The same frequency was used for the
baseline air-only data, even though there was no imposed periodicity in the
stimulus. Paired (across subjects) t-tests were performed to compare response
to the alternating stimuli and the air-only state. The ratio of
median correlation coefficients was calculated for the oxygen/carbogen stimulus
relative to each subject’s all-air control. This metric was compared between
two groups of volunteers scanned in different phases of the menstrual cycle to explore
the effect of hormonal changes on BOLD response.
Results
Activation maps and histograms
of pixel-wise correlation coefficients and phase lags for the air/carbogen and
oxygen/carbogen stimuli, compared to air-only breathing are shown in Figure 2. Of the
four stimulus combinations tested, oxygen/carbogen produced a response that
was significantly stronger (p<0.05) than the air-only control in volunteers
(Table 1). Subjects imaged during the follicular phase of their cycle (~days
10-20), when estrogen levels typically peak
6, exhibited a significantly smaller
BOLD response (p=0.011), compared to those in the menstrual or luteal phases of
their cycle (Figure 3). Response to the oxygen/carbogen stimulus in malignant
tissue was variable, with two lesions exhibiting a significant response to the
gas stimulus, whilst three showed a diminished response relative to surrounding
parenchyma (Figure 4).
Discussion
A measurable BOLD effect was
observed in healthy breast parenchyma in response to oxygen vs. 5% carbogen,
above the demonstrated level of normal physiological fluctuations seen with air.
This is consistent with the opposing vasomotor effects of these two gases. Our
results suggest changes should be characterized with respect to normal air variations to help account for inter-subject variations in background physiological
noise. Additionally, higher estrogen levels appear to suppress vasomotor
response. The diversity of response seen in tumors suggests this technique may be sensitive to the underlying vasculature, which warrants further investigation to
correlate BOLD contrast changes with histological markers of vessel maturity
and with therapy response.
Acknowledgements
This work was supported by the NIHR
Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer
Medicine Centre and the CRUK-EPSRC Cancer Imaging Centre in Cambridge and Manchester (C8742/A18097).References
1. Neeman M,
Dafni H, Bukhari O, et al. In vivo BOLD contrast
MRI mapping of subcutaneous vascular function and maturation: validation by
intravital microscopy. Magn. Reson. Med. 2001;45:887–98.
2. Gilad AA, Israely T, Dafni H, et al. Functional
and molecular mapping of uncoupling between vascular permeability and loss of
vascular maturation in ovarian carcinoma xenografts: The role of stroma cells
in tumor angiogenesis. Int. J. Cancer 2005;117:202–11.
3. Rakow-Penner R, Daniel B and Glover GH. Detecting blood oxygen level-dependent (BOLD) contrast in the
breast. J. Magn. Reson. Imaging 2010;32:120–29.
4. Carpenter CM, Rakow-Penner R, Jiang S, et al.
Monitoring of hemodynamic changes induced in the healthy breast through
inspired gas stimuli with MR-guided diffuse optical imaging. Med. Phys. 2010;37:1638–46.
5. Rueckert D, Sonoda LI, Hayes C, et al. Nonrigid
registration using free-form deformations: application to breast MR images. IEEE
Trans. Med. Imaging 1999;18:712–21.
6. Haggstrom M. Reference ranges for estradiol, progesterone, luteinizing hormone and follicle-stimulating hormone during
the menstrual cycle. Wikiversity J Med 2014;1.